Most legacy clinical trial management systems are cumbersome, making it difficult  to optimize trials and accelerate study execution. Unwieldy third-party integrations with EDC, partner systems or other point solutions means that upgrading to a more intuitive approach often entails replacing all current components. Yet, these antiquated systems have tremendous influence over trial execution, including transacting site payments and achieving compliance.

Join us to understand how organizations are moving into the next era of unparalleled data integration, seamless connectivity and intuitive design. Join us to  learn how a clinical trial management system’s design can support flexible business models, enabling decentralized trials and supporting early-phase through global mega-trials. Understand how real-time data aggregation  ensures stakeholders engagement and collaboration on the latest near real time data inclusive of multiple systems, such as:

  • Global Dashboards for better communication between patients, sites, and sponsors
  • Workflows with embedded intelligence for next best action
  • Pro-active data cleaning processes  creating a faster path to database lock for quality by design that results in closed loop issue management

Technologies that foster collaboration to produce a single source of clinical trial data throughout the trial lifecycle resulting in transparency across  in-house and partner e-clinical solutions contributing for holistic study management.

Featured Speakers

Melissa Easy

VP of Offerings R&D Strategy
IQVIA

Melissa Easy is Vice-President of Clinical Technology Offerings as part of IQVIA Technologies, responsible for the strategy and development of technology portfolio and technology-enabled services that improve clinical trial delivery for IQVIA and customer clinical trials more efficiently. She believes we must take advantage of orchestrated technology to bring patients, sites, and sponsors together in a concerted effort to save time, money, and lives.

Melissa founded DrugDev in 2009, establishing its reputation as an industry disruptor, and built collaborative relationships to become a trusted partner for many leading pharmaceutical companies. DrugDev grew organically and through acquisition until it was acquired by IQVIA in July 2017. Prior to founding DrugDev, Melissa held many roles as a consultant to CROs and sponsors, where she accumulated insight into industry inefficiencies and resultant frustrations, and formulated the concept for DrugDev.

Melissa earned a bachelor’s degree in biotechnology and microbiology from the University of Technology, Sydney and has received many awards, including being named as a PharmaVOICE 100 most influential people in life sciences, winning the ‘Partnerships in Clinical Trials Woman of the Year Award’ and being named by the Philadelphia Business Journal as a ‘Healthcare Innovator’, one of the ‘Top 40 Under 40’ and a ‘Woman of Distinction’. Most recently she was named as an HBA Luminary.

Beenu Kapoor

VP, Product Development
IQVIA

Beenu Kapoor is a creator of platform technology products leveraging her Business Operations, IT, Product Development and Consulting skills to augment digital transformation in R&D Clinical Development. Beenu has more than 25 years of experience focused on driving business outcomes by defining and implementing strategies, roadmaps, solutions involving innovative business operating models, process redesign and technology digitization agenda. She is currently serving as a leader on the IQVIA Technology team responsible for market facing Trial Management Product Suite. She is currently serving as a leader on the IQVIA Technology team responsible for market facing Digital Trial Management Suite (DTMS) of products.

NOW AVAILABLE ON-DEMAND

Register now for this webinar